Načítá se...
Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
SIMPLE SUMMARY: This review was aimed at exploring the potentiality of drugging the endocannabinoid system as a therapeutic option for Alzheimer’s disease (AD). Recent discoveries have demonstrated how the modulation of cannabinoid receptor 1 (CB1) and receptor 2 (CB2) can exert neuroprotective effe...
Uloženo v:
| Vydáno v: | Biology (Basel) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8234911/ https://ncbi.nlm.nih.gov/pubmed/34204237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biology10060542 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|